ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 82 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 1.9%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,000 | +40.0% | 14,024 | +75.3% | 0.00% | – |
| Q2 2023 | $30,000 | +57.9% | 7,998 | +38.5% | 0.00% | – |
| Q1 2023 | $19,000 | -63.5% | 5,774 | -45.9% | 0.00% | – |
| Q4 2022 | $52,000 | +100.0% | 10,664 | +135.1% | 0.00% | – |
| Q3 2022 | $26,000 | +73.3% | 4,536 | +123.6% | 0.00% | – |
| Q2 2022 | $15,000 | -63.4% | 2,029 | -63.6% | 0.00% | – |
| Q1 2022 | $41,000 | -59.0% | 5,568 | -50.5% | 0.00% | – |
| Q4 2021 | $100,000 | -65.5% | 11,249 | +36.4% | 0.00% | – |
| Q3 2021 | $290,000 | +118.0% | 8,247 | +33.9% | 0.00% | – |
| Q2 2021 | $133,000 | +121.7% | 6,157 | +530.2% | 0.00% | – |
| Q1 2021 | $60,000 | +300.0% | 977 | +169.9% | 0.00% | – |
| Q4 2020 | $15,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |